Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets raise concerns for future of ketamine   
Dr Silver
Dr Ganga de Silva, president of the Society of Companion Animal Practitioners.

WSAVA petition secures over 11,000 signatures

All veterinary surgeries in Sri Lanka would cease to operate if ketamine was not available. That's according to Dr Ganga de Silva, president of the Society of Companion Animal Practitioners of Sri Lanka.

In 2014, China called for a worldwide ban on ketamine following widespread misconception that it is only a ‘recreational drug’. But Dr Silva says that almost all veterinary surgeons in Sri Lanka rely on ketamine for anaesthesia.

"The result would be suffering for animals and it would seriously impact our ability to control rabies as we would not be able to carry out spay and neuter programs on stray dogs," she said.

Earlier this year the WSAVA launched an online petition to secure access to ketamine as an essential veterinary medicine. So far, the petition has received over 11,300 signatures - with 15,000 the next milestone.

The petition followed a review by the World Health Organisation that concluded ketamine does not cause a global public health threat and that control would limit access for those using it as an anaesthetic.

This view was confirmed at a meeting of the UN Commission on Narcotic Drugs in March 2016, helped by support from the global medical and veterinary communities. However, China has since repeated its view that ketamine should fall under international scheduling.

"Ketamine is a safe anaesthetic which can be used without oxygen, ventilators, electricity and the support systems required for other products, making it the only anaesthetic suitable for both medical and veterinary use in lower and middle-income countries," said WSAVA president Dr Walk Ingwersen.

"If developing countries were denied access to it, which would be the effect of international scheduling, the effects on veterinary medicine, human health and animal welfare would be devastating,” he said.

Dr Nancy Shaffran, president of the International Veterinary Academy of Pain Management, added: “In addition to its use as an anaesthetic agent, ketamine is a critical medication used in the pain management in animals. The mechanism of action of ketamine (NMDA receptor antagonism) delivered as a Constant Rate Infusion has been well established to be effective in the prevention and correction of severe neuropathic pain and spinal cord wind-up. 

“The loss of ketamine in veterinary practice would result in the needless suffering of many patients and we strongly oppose this action." 

The WSAVA are continuing with their push to secure the future of ketamine as a veterinary and human medicine. All those interested can sign the petition at http://chn.ge/1RFSou6

Image (C) WSAVA

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.